Improved sgp130Fc dimers

Details for Australian Patent Application No. 2007263939 (hide)

Owner Conaris Research Institute AG

Inventors Watzig, Georg H.; Seegert, Dirk

Agent Davies Collison Cave

Pub. Number AU-B-2007263939

PCT Pub. Number WO2008/000516

Priority 06013668.6 30.06.06 EP

Filing date 29 June 2007

Wipo publication date 3 January 2008

Acceptance publication date 24 November 2011

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C07K 14/43 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/000516 Priority application(s): WO2008/000516

24 November 2011 Application Accepted

  Published as AU-B-2007263939

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263944-18-methyl-19-nor-androst-4-en-17,17-s piroether (18-methyl-19-nor-20spirox4-en-3-one) and pharmaceutical preparations containing the same

2007263936-Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction